DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Beer TM, Kwon ED, Drake CG. et al.
Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer.
J Clin Oncol 2017;
35 (01) 40-47
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.